OncoMed Pharmaceuticals Inc Insider Trading for July 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OncoMed Pharmaceuticals Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in OncoMed Pharmaceuticals Inc for July 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 30 2014 | OMED | OncoMed Pharmaceut ... | HASTINGS PAUL J | Chairman & CEO | Option Exercise | M | 1.43 | 8,385 | 11,991 | 59,507 | |
| Jul 30 2014 | OMED | OncoMed Pharmaceut ... | HASTINGS PAUL J | Chairman & CEO | Option Exercise | M | 1.43 | 8,385 | 11,991 | 67,892 | |
| Jul 30 2014 | OMED | OncoMed Pharmaceut ... | HASTINGS PAUL J | Chairman & CEO | Sell | S | 22.28 | 8,385 | 186,802 | 22,500 | 30.9 K to 22.5 K (-27.15 %) |
| Jul 30 2014 | OMED | OncoMed Pharmaceut ... | HASTINGS PAUL J | Chairman & CEO | Buy | M | 1.43 | 8,385 | 11,991 | 30,885 | 22.5 K to 30.9 K (+37.27 %) |
| Jul 30 2014 | OMED | OncoMed Pharmaceut ... | HASTINGS PAUL J | Chairman & CEO | Sell | S | 22.70 | 100 | 2,270 | 22,500 | 22.6 K to 22.5 K (-0.44 %) |
| Jul 30 2014 | OMED | OncoMed Pharmaceut ... | HASTINGS PAUL J | Chairman & CEO | Sell | S | 21.93 | 8,285 | 181,666 | 22,600 | 30.9 K to 22.6 K (-26.83 %) |
| Jul 30 2014 | OMED | OncoMed Pharmaceut ... | HASTINGS PAUL J | Chairman & CEO | Buy | M | 1.43 | 8,385 | 11,991 | 30,885 | 22.5 K to 30.9 K (+37.27 %) |
| Jul 25 2014 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Option Exercise | M | 4.56 | 1,500 | 6,840 | 172,437 | |
| Jul 25 2014 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Sell | S | 23.00 | 1,500 | 34,500 | 20,896 | 22.4 K to 20.9 K (-6.70 %) |
| Jul 25 2014 | OMED | OncoMed Pharmaceut ... | Dupont Jakob | SVP & Chief Medical ... | Buy | M | 4.56 | 1,500 | 6,840 | 22,396 | 20.9 K to 22.4 K (+7.18 %) |
| Jul 18 2014 | OMED | OncoMed Pharmaceut ... | Gurney Austin | See Remarks | Sell | S | 20.46 | 4,000 | 81,853 | 101,532 | 105.5 K to 101.5 K (-3.79 %) |
| Jul 03 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Option Exercise | M | 1.43 | 4,000 | 5,720 | 68,277 | |
| Jul 03 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 24.36 | 704 | 17,151 | 20,000 | 20.7 K to 20 K (-3.40 %) |
| Jul 03 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Sell | S | 23.75 | 3,296 | 78,283 | 20,704 | 24 K to 20.7 K (-13.73 %) |
| Jul 03 2014 | OMED | OncoMed Pharmaceut ... | Lewicki John A. | EVP & Chief Scienti ... | Buy | M | 1.43 | 4,000 | 5,720 | 24,000 | 20 K to 24 K (+20.00 %) |
| Jul 02 2014 | OMED | OncoMed Pharmaceut ... | Pollard-Knight Denise | Director | Sell | S | 23.59 | 11,485 | 270,919 | 2,043,509 | 2.1 M to 2 M (-0.56 %) |